• News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter
  • Voices
  • Not To Miss
  • FDA Approvals
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Celebrities and Cancer
  • Immune Oncology
  • Breast Oncology
  • Gastrointestinal Oncology
  • Lung Oncology
  • Hematology
  • Radiotherapy
  • Cancer Types
  • Science
  • Trial Updates
  • ASCO
  • ESMO
  • ESO
  • MASCC
  • Cancer Center Near Me
  • Oncologist Near Me
  • OncoDaily Party 2025
  • Childhood Cancer
  • Health Policy
  • Hall of Fame
  • OncoIndustry
  • Public Health
  • Oncology Tech
  • Blog Posts
  • BIGR
  • Global Cancer Movement
  • History
  • Oncolibrary
  • OncoThon 2025
  • Yvonne Award 2025
Double Left Left Jun / 2026 Right Double Right
June 2026
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
« May    
OncodailyJournal CancerWorld OncoDaily IO OncoDaily GI Hemostasis Today Fertility News
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Voices
  • Not To Miss
  • FDA Approvals
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
  • News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter

Breast Cancer Highlights From ASCO 2026: ADCs, Biomarkers, and Earlier Treatment Strategies Take Center Stage

Amol Akhade: What The Devil Wears Prada 2 Taught Me About Oncology?

Alexandre Chan: Real-World Safety of Antibody–Drug Conjugates

ESTRO-EORTC Expert Guideline on Target Delineation and Radiotherapy for Stage I–III Small Cell Lung Cancer

Christopher Jackson: If Innovation Is the Heart of Oncology, Then Access Must Be Its Conscience

Hesham ElGhazaly: Meeting Global Oncology Leaders at ASCO 2026

Khizra Ahmad: Covering ASCO26 from Front-Row Seat as OncoDaily Ambassador

IMMUNIB Study Uptades: Nivolumab Plus Lenvatinib in Unresectable HCC

OncoCalendar

3 events found.

Events

Events Search and Views Navigation

Event Views Navigation

  • List
  • Month
Today
  • September 2027

  • Fri 17
    ESMO Congress 2027

    ESMO Congress 2027

    Sep 17, 2027 - Sep 21, 2027
    Barcelona, Spain

    The ESMO Congress 2027 will take place in Barcelona, Spain, from September 17–21, 2027. This event is recognized as a leading global oncology meeting that serves as a platform for […]

  • Thu 30
    Indian Cancer Congress

    Indian Cancer Congress 2027

    Sep 30, 2027 - Oct 3, 2027
    Chennai Trade Centre CTC Complex, Nandambakkam, Mount Poonamallee Road, Chennai, Tamil Nadu, India

    The 4th Indian Cancer Congress (ICC 4.0), a landmark event for the Indian and global oncology community, will take place from September 30 to October 3, 2027, in Chennai, India. […]

  • November 2027

  • Wed 24
    World Cancer Leaders' Summit

    World Cancer Leaders’ Summit 2027

    Nov 24, 2027 - Nov 28, 2027
    Kenyatta International Convention Centre Harambee Avenue, City Square, Nairobi, Kenya

    The World Cancer Leaders' Summit 2027 is a high-level policy event organized by the Union for International Cancer Control (UICC) and hosted by the National Cancer Institute of Kenya. The […]

  • Previous Events
  • Today
  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live
  • Export .ics file
  • Export Outlook .ics file
CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

LinkedIn X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
About Privacy Policy Editorial Policy Cookie Policy Disclaimer
Crafted by Matemat
Oncology OncoDaily cancer Breast Cancer fight against cancer ASCO Global fight against cancer cancer care Lung cancer Cancer research Headlines ESMO immunotherapy NSCLC MD Anderson Cancer Center cancer treatment cancer awareness colorectal cancer Research clinical trials Childhood Cancer ASCO24 AACR FDA prostate cancer UICC Dana-Farber Cancer Institute American Cancer Society chemotherapy SIOP European Cancer Organisation Pancreatic Cancer Robert Orlowski American Society of Clinical Oncology Myeloma Paper of the Day Paolo Tarantino NCI Myeloma Vivek Subbiah radiation oncology AI National Cancer Institute cervical cancer WHO IASLC healthcare Memorial Sloan Kettering Cancer Center multiple myeloma bladder cancer radiotherapy

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}